H.T. Begay is a happy kid. He’s smiley, silly, and definitely trying to make you laugh. The four-year-old’s two neat braids of dark hair wave behind him as he runs among the dust, dogs, and sheep near his family’s ranch on their Navajo reservation in Arizona.
On a table inside the family’s sweat lodge is a little altar, as shown in a video shared by the University of California, San Francisco. Next to a pair of tiny baby booties is a certificate that reads, “The first patient in the world to receive Autologous Gene Therapy for Artemis-deficient SCID 06/23/2018.”
Even though he was born without an immune system, H.T. can play with “all those animals and the diseases that those animals carry” and be completely fine, his doctor Morton Cowan says with a chuckle. That’s thanks to a new gene therapy that corrected the mutated gene called Artemis that prevented H.T. from being able to form T cells and B cells.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect